Literature DB >> 19243235

Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress.

Ira Tabas1.   

Abstract

Atherothrombotic vascular diseases, such as myocardial infarction and stroke, are the leading causes of death in the industrialized world. The immediate cause of these diseases is acute occlusive thrombosis in medium-sized arteries feeding critical organs. Thrombosis is triggered by the rupture or erosion of a minority of atherosclerotic plaques that have advanced to a particular stage of "vulnerability." Vulnerable plaques are characterized by certain key features, such as inflammation, thinning of a protective collagenous cap, and a lipid-rich necrotic core consisting of macrophage debris. A number of cellular events contribute to vulnerable plaque formation, including secretion of pro-inflammatory, procoagulant, and proteolytic molecules by macrophages as well as the death of macrophages, intimal smooth muscles cells, and possibly endothelial cells. The necrotic core in particular is a key factor in plaque vulnerability, because macrophage debris promotes inflammation, plaque instability, and thrombosis. Plaque necrosis arises from a combination of lesional macrophage apoptosis and defective clearance of these dead cells, a process called efferocytosis. This review focuses on how macrophage apoptosis, in the setting of defective efferocytosis, contributes to necrotic core formation and how a process known to be prominent in advanced lesions--activation of ER stress signal-transduction pathways--contributes to macrophage apoptosis in these plaques.

Entities:  

Mesh:

Year:  2009        PMID: 19243235      PMCID: PMC2787884          DOI: 10.1089/ars.2009.2469

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  52 in total

1.  Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.

Authors:  Edward Thorp; Gang Li; Tracie A Seimon; George Kuriakose; David Ron; Ira Tabas
Journal:  Cell Metab       Date:  2009-05       Impact factor: 27.287

Review 2.  Lipoproteins and atherosclerosis. A look back and a look ahead.

Authors:  D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Jul-Aug

Review 3.  Mechanisms and consequences of macrophage apoptosis in atherosclerosis.

Authors:  Tracie Seimon; Ira Tabas
Journal:  J Lipid Res       Date:  2008-10-25       Impact factor: 5.922

Review 4.  Macrophages and atherosclerotic plaque stability.

Authors:  P Libby; Y J Geng; M Aikawa; U Schoenbeck; F Mach; S K Clinton; G K Sukhova; R T Lee
Journal:  Curr Opin Lipidol       Date:  1996-10       Impact factor: 4.776

5.  Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice.

Authors:  Tracie A Seimon; Yibin Wang; Seongah Han; Takafumi Senokuchi; Dorien M Schrijvers; George Kuriakose; Alan R Tall; Ira A Tabas
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

6.  Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol.

Authors:  G J Warner; G Stoudt; M Bamberger; W J Johnson; G H Rothblat
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

7.  Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.

Authors:  Jennifer J Manning-Tobin; Kathryn J Moore; Tracie A Seimon; Susan A Bell; Maia Sharuk; Jacqueline I Alvarez-Leite; Menno P J de Winther; Ira Tabas; Mason W Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-23       Impact factor: 8.311

8.  Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma.

Authors:  R Y Ball; E C Stowers; J H Burton; N R Cary; J N Skepper; M J Mitchinson
Journal:  Atherosclerosis       Date:  1995-04-07       Impact factor: 5.162

9.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

Authors:  J D Smith; E Trogan; M Ginsberg; C Grigaux; J Tian; M Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  Signal transducer and activator of transcription-1 is critical for apoptosis in macrophages subjected to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo.

Authors:  Wah-Seng Lim; Jenelle M Timmins; Tracie A Seimon; Anthony Sadler; Frank D Kolodgie; Renu Virmani; Ira Tabas
Journal:  Circulation       Date:  2008-01-28       Impact factor: 29.690

View more
  60 in total

1.  Increased size and cellularity of advanced atherosclerotic lesions in mice with endothelial overexpression of the human TRPC3 channel.

Authors:  Kathryn B Smedlund; Lutz Birnbaumer; Guillermo Vazquez
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  Methods and models for monitoring UPR-associated macrophage death during advanced atherosclerosis.

Authors:  Edward B Thorp
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

3.  Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-10       Impact factor: 4.733

Review 4.  Importance of receptor-targeted systems in the battle against atherosclerosis.

Authors:  Elisabet Rosas; Igor Sobenin; Alexander Orekhov; Elazer R Edelman; Mercedes Balcells
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

6.  Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation.

Authors:  Qiang Cao; Xianfeng Wang; Lin Jia; Ashis K Mondal; Abdoulaye Diallo; Gregory A Hawkins; Swapan K Das; John S Parks; Liqing Yu; Huidong Shi; Hang Shi; Bingzhong Xue
Journal:  Endocrinology       Date:  2014-09-24       Impact factor: 4.736

7.  Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Authors:  Rabea Asleh; John Ward; Nina S Levy; Shady Safuri; Doron Aronson; Andrew P Levy
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

8.  Combined two-photon luminescence microscopy and OCT for macrophage detection in the hypercholesterolemic rabbit aorta using plasmonic gold nanorose.

Authors:  Tianyi Wang; J Jacob Mancuso; S M Shams Kazmi; Jordan Dwelle; Veronika Sapozhnikova; Brian Willsey; Li L Ma; Jinze Qiu; Xiankai Li; Andrew K Dunn; Keith P Johnston; Marc D Feldman; Thomas E Milner
Journal:  Lasers Surg Med       Date:  2012-01-03       Impact factor: 4.025

9.  Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis.

Authors:  Marc C Pulanco; Jason Cosman; Minh-Minh Ho; Jessica Huynh; Karina Fing; Jacqueline Turcu; Deborah A Fraser
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

Review 10.  Inflammasomes: a preclinical assessment of targeting in atherosclerosis.

Authors:  Jeremiah Stitham; Astrid Rodriguez-Velez; Xiangyu Zhang; Se-Jin Jeong; Babak Razani
Journal:  Expert Opin Ther Targets       Date:  2020-08-06       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.